Abstract:Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disorder that is closely associated with insulin resistance and type 2 diabetes. Previous studies have suggested that hepatocyte nuclear factor 1b (HNF1b) ameliorates insulin resistance. However, the role of HNF1b in the regulation of lipid metabolism and hepatic steatosis remains poorly understood. We found that HNF1b expression was decreased in steatotic livers. We injected mice with lentivirus (LV) expressing HNF1b shRNA to generate mice with hepatic knockdown of HNF1b. We also injected high fat (HF) diet-induced obese and db/db diabetic mice with LV expressing HNF1b to overexpress HNF1b. Knockdown of HNF1b increased hepatic lipid contents and induced insulin resistance in mice and in hepatocytes. Knockdown of HNF1b worsened HF diet-induced increases in hepatic lipid contents, liver injury and insulin resistance in mice and PA-induced lipid accumulation and impaired insulin signaling in hepatocytes. Moreover, overexpression of HNF1b alleviated HF diet-induced increases in hepatic lipid content and insulin resistance in mice. Knockdown of HNF1b increased expression of genes associated with lipogenensis and endoplasmic reticulum (ER) stress. DPP4 and NOX1 expression was increased by knockdown of HNF1b and HNF1b directly bound with the promoters of DPP4 and NOX1. Overexpression of DPP4 or NOX1 was associated with an increase in lipid droplets in hepatocytes and decreased expression of DPP4 or NOX1 suppressed the effects of knockdown of HNF1b knockdown on triglyceride (TG) formation and insulin signaling. Knockdown of HNF1b increased superoxide level and decreased glutathione content, which was inhibited by downregulation of DPP4 and NOX1. N-acetylcysteine (NAC) suppressed HNF1b knockdown-induced ER stress, TG formation and insulin resistance. Palmitic acid (PA) decreased HNF1b expression which was inhibited by NAC. Taken together, these studies demonstrate that HNF1b plays an essential role in controlling hepatic TG homeostasis and insulin sensitivity by regulating DPP4/NOX1mediated generation of superoxide.

Reduced Nogo expression inhibits diet-induced metabolic disorders by regulating ChREBP and insulin activity

Inhibition of High-Fat Diet-Induced Obesity Via Reduction of ER-resident Protein Nogo Occurs Through Multiple Mechanisms

Nogo-B inhibition facilitates cholesterol metabolism to reduce hypercholesterolemia

NGBR is required to ameliorate type 2 diabetes in mice by enhancing insulin sensitivity

Nogo-B deficiency suppresses white adipogenesis by regulating β-catenin signaling

Intestinal Nogo-B reduces GLP1 levels by binding to proglucagon on the endoplasmic reticulum to inhibit PCSK1 cleavage

Lipogenic Transcription Factor ChREBP Mediates Fructose-Induced Metabolic Adaptations to Prevent Hepatotoxicity

Knockdown of Neuropeptide Y in the Dorsomedial Hypothalamus Promotes Hepatic Insulin Sensitivity in Male Rats

6-Methyl flavone inhibits Nogo-B expression and improves high fructose diet-induced liver injury in mice

Reduced intake of carbohydrate prevents the development of obesity and impaired glucose metabolism in ghrelin O-acyltransferase knockout mice

Overexpression of NgBR Inhibits High-Fat Diet–induced Atherosclerosis in ApoE-deficiency Mice

Identification of Nogo-B As a New Molecular Target of Peroxisome Proliferator-Activated Receptor Gamma.

Nicotinamide riboside ameliorates high-fructose-induced lipid metabolism disorder in mice via improving FGF21 resistance in the liver and white adipose tissue

Inhibition of Nogo-B Reduces the Progression of Pancreatic Cancer by Regulation NF-κB/GLUT1 and SREBP1 Pathways

LncRNA Nron deficiency protects mice from diet-induced adiposity and hepatic steatosis

Niemann-Pick C1-Like 1 Deletion in Mice Prevents High-Fat Diet-Induced Fatty Liver by Reducing Lipogenesis

Inhibition of Hepatocyte Nuclear Factor 1b Induces Hepatic Steatosis Through DPP4/NOX1-mediated Regulation of Superoxide.

Both prolonged high-fat diet consumption and calorie restriction boost hepatic NAD+ metabolism in mice.

Protective effects of Nogo-B deficiency in NAFLD mice and its multiomics analysis of gut microbiology and metabolism

NRG1-Fc Improves Metabolic Health Via Dual Hepatic and Central Action

High Glucose Reduces Hepatic Glycogenesis by Suppression of Microrna-152